Lerer Kenneth B 的 Form 4 申報
Strata Critical Medical, Inc.（SRTA），2022/5/27 申報
- 申報編號
- 0000899243-22-019994
- 申報時間
- 2022/5/27
- 交易日
- 2022/5/25-5/26
- 申報延遲
- 2 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 8 筆非衍生性交易。公開市場賣出合計 $331.2 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Lerer Kenneth BCIK 0001120789 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/5/25 | Class A common stock, $0.0001 par value per share | S賣出處分 | −3,931 | $7.11F1 | −$27,949.41 | 103,455 | 直接 | |
| 2022/5/25 | Class A common stock, $0.0001 par value per share | S賣出處分 | −8,602 | $7.11F1 | −$61,160.22 | 102,898 | 間接 | |
| 2022/5/25 | Class A common stock, $0.0001 par value per share | S賣出處分 | −53,916 | $7.11F1 | −$383,342.76 | 644,985 | 間接 | |
| 2022/5/25 | Class A common stock, $0.0001 par value per share | S賣出處分 | −28,851 | $7.11F1 | −$205,130.61 | 345,137 | 間接 | |
| 2022/5/26 | Class A common stock, $0.0001 par value per share | S賣出處分 | −47,029 | $7.03F6 | −$330,613.87 | 56,426 | 直接 | |
| 2022/5/25 | Class A common stock, $0.0001 par value per share | S賣出處分 | −102,898 | $7.03F6 | −$723,372.94 | 0 | 間接 | |
| 2022/5/26 | Class A common stock, $0.0001 par value per share | S賣出處分 | −146,873 | $7.01F7 | −$1,029,579.73 | 498,112 | 間接 | |
| 2022/5/26 | Class A common stock, $0.0001 par value per share | S賣出處分 | −78,593 | $7.01F7 | −$550,936.93 | 266,544 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
These transactions were executed in multiple trades at prices ranging from $7.01 to $7.21, inclusive. The price reported above reflects the weighted average sale price. The Reporting Persons hereby undertake to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range.
表 I 有 4 筆交易的價格引用這則附註。
- F6
These transactions were executed in multiple trades at prices ranging from $7.00 to $7.20, inclusive. The price reported above reflects the weighted average sale price. The Reporting Persons hereby undertake to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range.
表 I 有 2 筆交易的價格引用這則附註。
- F7
These transactions were executed in multiple trades at prices ranging from $6.915 to $7.240, inclusive. The price reported above reflects the weighted average sale price. The Reporting Persons hereby undertake to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range.
表 I 有 2 筆交易的價格引用這則附註。